本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kalvista Pharmaceuticals Inc

21.00
+1.105.54%
成交量:77.51万
成交额:1,598.89万
市值:10.76亿
市盈率:-5.25
高:21.20
开:19.92
低:19.87
收:19.90
52周最高:21.31
52周最低:9.24
股本:5,122.25万
流通股本:2,791.69万
量比:0.78
换手率:2.78%
股息:- -
股息率:- -
每股收益(TTM):-3.9996
每股收益(LYR):-3.0497
净资产收益率:-190.18%
总资产收益率:-60.98%
市净率:-396.84
市盈率(LYR):-6.89

数据加载中...

2024/07/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/06/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/22

重要事件披露

Form 8-K - Current report
2024/04/02

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/26

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/22

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/16

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities